High rates of resistance to second line drugs are routinely encountered in Mumbai, India for XDR-TB; highlighting the need for new agents

被引：1
|
作者：
Banka, Radhika
Mullerpattan, Jai
Ganatra, Shashank
Udwadia, Zarir
Rodrigues, Camilla
Parmar, Ajay
Khillari, Archana
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷
关键词：
D O I：
10.1183/1393003.congress-2017.OA4855
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA4855
引用
收藏
页数：2
相关论文
共 4 条
  • [1] Bacteriological conversion in XDR-TB and RR-TB patients with fluoroquinolone resistance treated with and without new and repurposed anti-TB drugs in Azerbaijan prisons
    Gurbanova, Elmira
    Mehdiyev, Rafail
    Blondal, Kai
    Altraja, Alan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [2] High prevalence of resistance to second-line anti-TB drugs
    [J]. Reactions Weekly, 2012, 1418 (1) : 4 - 4
  • [3] Diagnostic accuracy of the Xpert® MTB/XDR assay for detection of Isoniazid and second-line antituberculosis drugs resistance at central TB reference laboratory in Tanzania
    Maya, Togolani
    Wilfred, Aman
    Lubinza, Clara
    Mfaume, Saidi
    Mafie, Maryjeska
    Mtunga, Daphne
    Kingalu, Amri
    Mgina, Nicodem
    Petrucka, Pammla
    Doulla, Basra E.
    Ngadaya, Esther
    Mfinanga, Sayoki G.
    Mnyambwa, Nicholaus P.
    [J]. BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [4] Eastern Cape Province Has High Levels Of Resistance To Injectable Second-Line Drugs In Patients Starting Treatment For MDR-TB
    Kvasnovsky, C.
    Odendaal, R.
    Brand, J.
    Lancaster, J.
    Dalton, T.
    Wolfgang, M.
    van der Walt, M.
    Ershova, J.
    Cegielski, J. P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
1